Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New drugs could help fight antibiotic resistance
Image pills
Current antibiotics work by killing bacteria, or stopping it from growing.
AV drugs stop bacteria from harming the host

Scientists say a new type of drug could help fight antibiotic resistance, by stopping bacteria from harming the host.

Current antibiotics aim to kill bacteria, or stop them growing, but scientists from the University of Edinburgh say this dramatically alters how the bugs evolve and helps resistant strains to survive.

After conducting a five-year review of research in the field, scientists believe anti-virulence (AV) drugs could stop the growing resistance to antibiotics.

AV drugs work by stopping the harmful part of the bacteria from functioning - without directly harming or killing the bugs. In this way, the treat the infection without promoting drug resistance.

Experts warn that as antibiotic resistance grows, curable infections could become life-threatening if the bacteria responsible becomes immune to current treatments.

According to the team from Edinburgh, recent research suggests AV drugs could provide an effective and longer lasting alternative to existing treatments.

Findings indicate the new drugs could work well alone, or combined with existing drugs.

"Our findings reveal that there are opportunities to make real progress in the fight against antibiotic resistance," said researcher Richard Allen.

"Gaining a greater understanding of how virulence affects bacterial growth in the host should aid us in our efforts to develop effective AV drugs."

The study has been published in the journal Nature Reviews Microbiology.

Become a member or log in to add this story to your CPD history

Submissions open for BSAVA Clinical Research Abstracts 2026

News Story 1
 The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.

It is an opportunity for applicants to present new research on any veterinary subject, such as the preliminary results of a study, discussion of a new technique or a description of an interesting case.

They must be based on high-quality clinical research conducted in industry, practice or academia, and summarised in 250 words.

Applications are welcome from vets, vet nurses, practice managers, and students.

Submissions are open until 6 March 2026. 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk